Literature DB >> 3880554

D-Galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice.

M Chojkier, J Fierer.   

Abstract

Two strains of mice (C57BL/10ScN and C3H/HeJ) that carry the same mutant lipopolysaccharide gene (Lpsd) which makes them resistant to the toxic effects of endotoxin (LPS) are also partially resistant to the hepatotoxic effects of D-galactosamine. As measured by serum alanine aminotransferase, the degree of liver injury induced by D-galactosamine in the LPS-resistant strains is only 10%-30% that of closely related strains of LPS-sensitive mice. Similarly, histopathologic changes are less pronounced in the endotoxin-resistant strains than in LPS-susceptible mice. By transferring spleen cells from LPS-susceptible strains to lethally irradiated, LPS-resistant mice, we established that susceptibility to D-galactosamine is mediated by lymphoreticular cells. Radiation-resistant spleen cells transferred D-galactosamine sensitivity, suggesting a role for macrophages. We did not exclude the possibility that lymphocytes can also transfer the response to D-galactosamine. These results establish that in mice, D-galactosamine sensitivity is associated with endotoxin sensitivity and that the former is mediated by lymphoreticular cells, not by hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880554     DOI: 10.1016/s0016-5085(85)80142-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Assessment of efficiency and safety of adenovirus mediated gene transfer into normal and damaged murine livers.

Authors:  T Nakatani; S Kuriyama; K Tominaga; T Tsujimoto; A Mitoro; M Yamazaki; H Tsujinoue; H Yoshiji; S Nagao; H Fukui
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Targeted protection of hepatocytes from galactosamine toxicity in vivo.

Authors:  V Keegan-Rogers; G Y Wu
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha.

Authors:  M Shito; U J Balis; R G Tompkins; M L Yarmush; M Toner
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

4.  An experimentally-induced acute hepatic failure model in various strains of mice.

Authors:  Y Mizoguchi; H Kuboi; H Tsutsui; S Seki; K Kobayashi; S Yamamoto; S Morisawa; I Yano
Journal:  Gastroenterol Jpn       Date:  1989-10

5.  Effects of urotensin-II on cytokines in early acute liver failure in mice.

Authors:  Liang-Ming Liu; Liang Zhao; Dong-Yu Liang; Fang-Ping Yu; Chang-Gen Ye; Wen-Juan Tu; Tong Zhu
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

6.  Hemorrhage-induced hepatic injury and hypoperfusion can be prevented by direct peritoneal resuscitation.

Authors:  Ryan T Hurt; El Rasheid Zakaria; Paul J Matheson; Mahoney E Cobb; John R Parker; R Neal Garrison
Journal:  J Gastrointest Surg       Date:  2009-01-31       Impact factor: 3.452

7.  Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia.

Authors:  M Buck; K Houglum; M Chojkier
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

8.  Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.

Authors:  M Leist; F Gantner; I Bohlinger; G Tiegs; P G Germann; A Wendel
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

9.  A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis.

Authors:  Martina Buck; Mario Chojkier
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

10.  C/EBPβ-Thr217 Phosphorylation Stimulates Macrophage Inflammasome Activation and Liver Injury.

Authors:  Martina Buck; Jose Solis-Herruzo; Mario Chojkier
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.